about
Mutual information optimization for mass spectra data alignment.Biomarkers discovery by peptide and protein profiling in biological fluids based on functionalized magnetic beads purification and mass spectrometry.Urinary signatures of Renal Cell Carcinoma investigated by peptidomic approaches.Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors.Downregulation of C3 and C4A/B complement factor fragments in plasma from patients with squamous cell carcinoma of the penis.Detection of high molecular weight proteins by MALDI imaging mass spectrometry.Non-invasively collected amniotic fluid as a source of possible biomarkers for premature rupture of membranes investigated by proteomic approach.The selected reaction monitoring/multiple reaction monitoring-based mass spectrometry approach for the accurate quantitation of proteins: clinical applications in the cardiovascular diseases.Normal human mitral valve proteome: A preliminary investigation by gel-based and gel-free proteomic approaches.Technological advances and proteomic applications in drug discovery and target deconvolution: identification of the pleiotropic effects of statins.Modulation of urinary peptidome in humans exposed to high altitude hypoxiaDifferent expression of Fibrinopeptide A and related fragments in serum of type 1 diabetic patients with nephropathyHuman urine biomarkers of renal cell carcinoma evaluated by ClinProtSerum Biomarkers of Renal Cell Carcinoma Assessed Using a Protein Profiling Approach Based on ClinProt Technique
P50
Q33881800-AF8DBF8D-7EFA-49D2-8227-FA761C0DD664Q33962458-D7A360C0-3C07-49B6-98FB-720D75C9AF78Q34155959-9D009097-155A-4AE8-851F-B5363A46363EQ34367975-F32B3731-9262-480B-8B8D-080224898A9AQ34542887-8D51EDE6-5693-4E5D-9A7E-BEB6AF2642E9Q34557652-EA306F43-170B-49D2-877F-944BAF865173Q34843763-8143E159-B5F3-4715-B150-0F356E2B94A2Q38268586-9A9B0BC4-1C8E-405D-93B8-8A916AFFA915Q38389725-6CC34CC1-890F-4558-B8F7-9BE800D71E66Q39174369-A08BDC0E-A0D1-4C08-8B83-9D4371DF9795Q57099063-4189D862-FA2F-49AF-87D4-5EC31D432A08Q57518520-926DAF1F-EABF-4A27-8BB2-7550338564E7Q61635722-ED924C0F-B64F-4ECE-B541-39F84ACD624FQ61635745-7388A995-B52F-4112-A357-F330C10001CD
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-2370-947X
@en
name
Erica Gianazza
@ast
Erica Gianazza
@en
Erica Gianazza
@es
Erica Gianazza
@nl
type
label
Erica Gianazza
@ast
Erica Gianazza
@en
Erica Gianazza
@es
Erica Gianazza
@nl
prefLabel
Erica Gianazza
@ast
Erica Gianazza
@en
Erica Gianazza
@es
Erica Gianazza
@nl
P106
P1153
24758035400
P21
P31
P496
0000-0003-2370-947X